Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

View CytoMed Therapeutics Limited GDTC stock quote prices, financial information, real-time forecasts, and company news from CNN.

Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...

Short interest in CytoMed Therapeutics Ltd (NASDAQ:GDTC) decreased during the last reporting period, falling from 65.20K to 56.79K. This put 1.73% of the company's publicly available shares short.

CytoMed (NASDAQ: GDTC) stock is up 100%. The rise in GDTC stock seems to be coming from the award of a patent. This is a very silly idea, quite ridiculous. Of course, it's just great for those who ...

CytoMed (NASDAQ: GDTC) stock is down 33% over the last 24 hours. GDTC stock fell in a mixture of real trading time, the aftermarket and now this morning. The reason for the decline is simply that it ...

On Monday, CytoMed Therapeutics (NASDAQ:GDTC) stock is down 6.35% at $3.23 at last check Monday. The Singapore-based clinical-stage biopharmaceutical entered into a five-year Business & Research ...